In a cohort study of 18,386 adults with overweight or obesity, the average reduction in body weight after three months of treatment for tirzepatide users was 5.9% compared to 3.6% for semaglutide users
Nutrition Target protein intake at 1.42.0 g/kg/day (higher end for older adults and active individuals) Prioritize high-quality, leucine-rich protein sources at each meal: eggs, fish, poultry, dairy, and lean meat Distribute protein across 34 meals, aiming for 2540 grams per meal When appetite suppression limits food protein, use a high-quality protein supplement or free-form EAA product to fill gaps Kion Clean Protein and Kion Aminos are designed for exactly this use case Do not allow protein intake to slip below 1.2 g/kg/day even on low-appetite days Training Perform resistance training at minimum 2x/week
$45.99 Glutathione Reduc 500 $45.99 Glutathione Reduc 500 mg Login for Willner pricing
Novo Nordisks Wegovy (semaglutide) has just earned accelerated FDA approval to treat MASH, becoming the first GLP-1 therapy cleared for this serious liver disease affecting ~5 % of U.S
Activated B cells and plasma cells are resistant to radiation therapy
Watch the additives